Objective: Understanding the regulation of adipocyte differentiation by cellular and extracellular factors is crucial for better management of chronic conditions such as obesity, insulin resistance and lipodystrophy. Experimental infection of rats with a human adenovirus type 36 (Ad-36) improves insulin sensitivity and promotes adipogenesis, reminiscent of the effect of thiozolinediones. Therefore, we investigated the role of Ad-36 as a novel regulator of the adipogenic process. Design and Results: Even in the absence of adipogenic inducers, infection of 3T3-L1 preadipocytes and human adipose-derived stem cells (hASC) by Ad-36, but not Ad-2 that is another human adenovirus, modulated regulatory points that spanned the entire adipogenic cascade ranging from the upregulation of cAMP, phosphatidylinositol 3-kinase and p38 signaling pathways, downregulation of Wnt10b expression, and increased expression of CCAAT/enhancer binding protein-b and peroxisome proliferator-activated receptor g2 and consequential lipid accumulation. Next, we identified that E4 open reading frame (orf)-1 gene of the virus is necessary and sufficient for Ad-36-induced adipogenesis. Selective knockdown of E4 orf-1 by RNAi abrogated Ad-36-induced adipogenic signaling cascade in 3T3-L1 cells and hASC. Compared to the null vector, selective expression of Ad-36 E4 orf-1 in 3T3-L1 induced adipogenesis, which was abrogated when the PDZ-binding domain of the protein was deleted. Conclusion: Thus, Ad-36 E4 orf-1 is a novel inducer of rodent and human adipocyte differentiation process.
Introduction
Recent evidence for the role of adipose tissue in energy balance and glucose metabolism (Rosen and Spiegelman 1 , review) has intensified the need for understanding the process of adipocyte differentiation. 2 Like excessive adiposity, impaired adipogenesis is associated with insulin resistance, 3 and insufficient adipose tissue causes glucose intolerance, which could be reversed by the presence of adipose tissue. [4] [5] [6] On the other hand, adequate lipid storage in the adipose tissue, 7 or induction of adipogenesis improves insulin sensitivity. [8] [9] [10] Therefore, understanding the regulation of adipocyte differentiation by cellular and extracellular factors is crucial for better management of chronic conditions such as obesity, insulin resistance and lipodystrophy.
Numerous regulators of adipogenesis have already been reported (Farmer 11 , review), and identification of additional modulators is likely to provide further insight into the process. Adenovirus type 36 (Ad-36) is a human adenovirus that increases adiposity in experimentally infected animal models, [12] [13] [14] [15] and shows an association with human obesity. 16 Experimental infection of rats with Ad-36 promoted adipogenesis and improved insulin sensitivity, reminiscent of the effects of thiozolinediones (TZD). 15 In vitro, Ad-36 enhanced lipid accumulation in 3T3-L1 cells in the presence of adipogenic-inducer cocktails (dexamethasone and insulin, MDI). 17 Whether Ad-36 can initiate adipogenesis as a primary effect in preadipocytes was unknown. The current study comprehensively determined if Ad-36 induced the adipogenic process ranging from cellular signaling pathways, expression of preadipocyte and adipocyte genes, to consequential lipid accumulation, in the absence of induction by MDI. Next, we investigated the specific adipogenic viral gene responsible for the Ad-36-induced adipogenesis. E4 open reading frame (orf)-1 gene product of other human adenoviruses reportedly upregulates phosphatidylinositol 3-kinase (PI3K) pathway via its PDZ-protein binding domain. 18 Considering the pivotal role of PI3K in adipogenesis, 19, 20 we tested the hypothesis that E4 orf-1 is the candidate gene necessary and sufficient for Ad-36-induced adipogenesis in murine and human preadipocytes.
Research design and methods
Experiment 1: Ad-36, not Ad-2, infection induces differentiation and lipid accumulation in 3T3-L1 CARD1 cells and hASC Ad-2, another human adenovirus, which lacks adipogenic activity in vivo and in vitro, 17, 21 was used as a negative control for viral infection. Although Ad-2 is nonadipogenic in animals, 21 it poorly infects 3T3-L1 cells, a rodent preadipocyte cell line. 22 To circumvent problems with Ad-2 infection, we used 3T3-L1 coxsackievirus and adenovirus receptor (CAR)D1 cells 23 that express the CAR required for Ad-2 entry 23 and still maintain their adipogenic differentiation ability. To determine the relevance of Ad-36-induced adipogenesis to humans, the effect of Ad-36 and Ad-2 infection was also studied in primary human adipose-derived stem cells (hASC). Both Ad-36 and Ad-2 efficiently infect 3T3-L1 CARD1 and hASC. Ad-36 and Ad-2 viruses were prepared as described in 'Techniques and assay' section. Confluent 3T3-L1 CARD1 cells and primary hASC isolated from adipose tissue of nonobese, healthy humans (isolated as described in 'Techniques and assay' section) were infected with the viruses as described ('Techniques and assay' section). Multiple parameters were used to determine the adipogenic effect of viruses on cells. Following serum deprivation to synchronize the cell cycle, effect of viral infection on cellular signaling including cAMP levels, and cAMP response element binding protein (CREBP), protein kinase B (PKB) and p38 mitogenactivated protein kinase (MAPK) phosphorylations were determined ('Techniques and assay' section). Expressions of cellular genes of adipogenic cascade and those of viral genes (to confirm viral entry) were determined ('Techniques and assay' section). Finally, the cellular lipid accumulation was determined by Oil Red O staining ('Techniques and assay' section). As described in 'Techniques and assay' section, cells were stained with lipid-specific dye BODIPY to visualize lipid accumulation over time.
Experiment 2: Ad-36 E4 orf-1 activity is sufficient for differentiation and lipid accumulation in 3T3-L1 cells To determine the adipogenic role of the candidate gene Ad-36 E4 orf-1, we constructed 3T3-L1 cells constitutively expressing either Ad-36 E4 orf-1, Ad-36 E4 orf-1 with the PDZ-domain deleted (dPDZ), or null retroviral vector ('Techniques and assay' section) (see Table 1 for DNA and amino-acid sequences). E4 orf-1 gene expression was verified by qRT-PCR ('Techniques and assay' section). After cell cycle synchronization by serum deprivation, effect of E4 orf-1 expression on cellular cAMP levels and PKB activity, cell proliferation, CCAAT/enhancer binding protein-b (C/EBP-b) gene expression and lipid accumulation was determined as described in 'Techniques and assay' section.
Experiment 3: Ad-36 E4 orf-1 activity is necessary for differentiation and lipid accumulation in 3T3-L1 cells and hASC To conclusively demonstrate that E4 orf-1 is required for Ad-36-induced adipogenesis, we used siRNA to selectively knock down E4 orf-1 expression in 3T3-L1 and hASC cultures infected with Ad-36 as described in 'Techniques and assay' section. We expected to observe abrogation of Ad-36-induced adipogenesis by knocking down E4 orf-1 expression. E4 orf-1 mRNA expression was measured to confirm the knockdown effect of siRNA. Next, the effects of E4 orf-1 siRNA on cAMP and PI3K pathways, proadipogenic gene expression and lipid accumulation in Ad-36-infected 3T3-L1 cells and in hASC cultures were determined as described in 'Techniques and assay' section. 17 Viral titers were determined by plaque assay 13 and cell inoculations were expressed as multiplicity of infection (MOI).
Isolation and culture of human ASCs. hASCs were isolated from liposuction aspirates from subcutaneous, abdominal adipose tissue of a healthy, female donor with a body mass index of 25 as described. 24 The stromal vascular fraction was resuspended in DME/F-12 þ 20% fetal bovine serum (FBS) þ antibiotic/antimycotic, and plated at a density of 0. . At confluency, culture media were removed and cells incubated for 1 h at 37 1C, 5% CO 2 with 100 ml cm À2 DME/ F-12 1:1 (mock), DME/F-12 1:1 þ Ad-2 (MOI 3.8) or DME/F-12 1:1 þ Ad-36 (MOI 3.8). Following infection, media were replaced with DME/F-12 1:
cAMP measurement. cAMP levels were assessed using a cAMP ELISA (BioVision Research Products, Mountain View, CA, USA). Samples and standards were solubilized in HCl prior to competitive binding a polyclonal antibody to cAMP coupled to horseradish-peroxidase. After substrate addition and termination of the enzymatic reaction, the intensity of the resulting blue color read on a microplate reader at 650 nm is inversely proportionally to the concentration of cAMP in either standard or samples.
PKB activity assay. PKB Activity was assessed using an in vitro assay (Cell Signaling Technology, Danvers, MA, USA). Immunoprecipitation of PKB from 250 mg cell extracts was followed by an in vitro kinase activity assay using glycogen synthase kinase (GSK)-3 fusion protein as substrate for cellular PKB. Phosphorylation of GSK-3 was measured by western blotting using phospho-GSK-3a/b (ser21/9) antibody. Blots are representative of the PKB activity present in the lysates.
Western blotting. Proteins were quantitated by BCA assay and loaded in equal amounts. Densitometry of autoradiographs was used for determining protein abundance.
Phosphorylation measurements were normalized to total gene of interest. A technical replicate (n ¼ 3) is represented in all figures.
Antibodies. Antibodies phospho-CREB (ser133, Sc-7978-R, Santa Cruz Biotech, Santa Cruz, CA, USA); total CREB (Sc-25785, Santa Cruz Biotech); phospho-PKB (ser473, 9271S, Cell Signaling), total PKB (9272, Cell Signaling); phospho-p38 (Thr180/Tyr182, 9211S, Cell Signaling) and total p38 (9212, Cell Signaling) were used.
qRT-PCR. Real-time quantitative PCR was conducted using ABI PRISM 7700 sequence detector (Applied Biosystems, Branchburg, NJ, USA) using a SYBR Green detection system (Bio-Rad, Hercules, CA, USA) or primer/probe (Applied Biosystems). A standard was generated using cDNA pooled from the experimental samples. Relative expression levels were determined by normalization to b-actin or cyclophilin and expressed as arbitrary units.
Primers and primer/probes. Primer/probe used to assess human (Wnt10b, C/EBP-b, peroxisome proliferator-activated receptor g2 (PPARg2), cyclophilin) gene expression was purchased from Applied Biosystems. Primers used with SYBR Green analysis:
Ad-2 primers:
Murine primers:
Lipid content. Lipid accumulation was assessed by Oil Red O staining of experimental cultures followed by alcohol extraction. 25 Lipid content was represented as absorbance/ cell by normalizing for cellular DNA. Statistics. All assays were performed at least in triplicate and reported as mean ± s.e.m. Student's t-test was utilized to determine significance (Po0.05). Bonferroni correction was used for multiple comparisons.
Results
Experiment 1: Ad-36, not Ad-2, infection induces differentiation and lipid accumulation in 3T3-L1 cells and hASC 3T3-L1 CARD1 cells. Robust mRNA expressions of E1A genes of Ad-2 and Ad-36 in 3T3-L1 CARD1 cells confirmed the entry of respective viruses in cells (data not shown). Despite the viral entry, only Ad-36, but not Ad-2, induced adipogenic pathway as determined by various markers of adipogenesis. Ad-36, but not Ad-2, activated cAMP and P13K pathways indicated by increased phosphorylation of CREB and PKB ( Figure 1A) , respectively. Furthermore, Ad-36 infection, but not Ad-2 initiated mitotic clonal expansion represented by an increase in cell proliferation ( Figure 1B) , followed by differentiation as evidenced by a decreased Wnt10b expression, increased C/EBP-b and PPARg2 expressions, and lipid accumulation ( Figure 1C ). It should be noted that the lipid accumulation was normalized to cell number. Considering the greater number of cells in Ad-36-infected group, effect of infection on total lipid accumulation is even more pronounced, if not normalized for cell number.
hASC. Ad-2 and Ad-36 viral gene expression was observed in experimentally infected hASC cultures (Figure 2A ), demonstrating successful viral infection. Despite the successful viral entry in cells, only Ad-36, but not Ad-2, induced adipogenesis in the absence of differentiation inducers. Ad-36, but not Ad-2, increased phosphorylation of CREB, PKB and p38 ( Figures 2B a-c) and increased proliferation ( Figure 2C ). p38 is required for differentiation of 3T3-L1 and human preadipocyte differentiation through phosphorylation of C/EBP-b. 26 Chronic activation of p38 MAPK is also reported recently in obesity induced by a parasite. 27 Ad-36-infected hASC cultures increased C/EBP-b gene expression and lipid accumulation, an effect not seen in Ad-2-infected hASC cultures ( Figure 2D ). Images of BODIPY staining showed that the cells infected with Ad-36 showed increasing lipid accumulation over time as indicated by increasing green fluorescence ( Figure 2E ). As expected in the absence of differentiation inducers, the mock-infected cells did not increase lipid accumulation over time. Narrow and elongated appearance characteristic of hASC is seen in the micrographs ( Figure 2E ). Collectively, these results show that even in the absence of MDI, Ad-36 induces adipogenesis in rodent preadipocyte cultures and human primary ASC, and the effect is not shared by all adenoviruses. (Figures 3B-D) . E4 orf-1 PDZ domain binds to PDZ domains of other proteins located at the C termini. Given that PDZ proteins are scaffolding proteins 28 that organize other proteins into functional groups and have pivotal roles in signal transduction and intercellular junctions, these data strongly suggest that the proadipogenic effect of E4 orf-1 involves intracellular signaling.
Experiment 3: Ad-36 E4 orf-1 activity is necessary for differentiation and lipid accumulation in 3T3-L1 cells and hASC E4 orf-1 siRNA greatly reduced E4 orf-1 mRNA levels 24 and 48 h post-infection in Ad-36-infected 3T3-L1 cells ( Figure 4A ) and completely abolished in hASC cultures 24 h postinfection (data not shown), confirming the desired effect of siRNA activity. As predicted, E4 orf-1 siRNA-mediated knockdown of E4 orf-1 gene expression resulted in the abolishment of the proadipogenic effects of Ad-36 on cAMP and PI3K pathways, proadipogenic genes, and lipid accumulation 
Discussion
Our results show induction of the adipogenic program in rodent and human adipocyte progenitors by Ad-36 via its E4 orf-1 gene product, an extracellular agent that naturally occurs in the environment. Human adenoviruses include about 50 known serotypes, of which Ad-5, Ad-36 and Ad-37 are reported to be adipogenic while Ad-2 and Ad-31 are nonadipogenic in vivo. 12-14,21,29 Adenoviral early gene E4 encodes six known E4 proteins (orfs 1-6). 30 Because of its role in host cell cycle regulation and host cell transformation, E4 orf-1 was our candidate gene for proadipogenic influences on proliferation and differentiation of preadipocytes. As hypothesized, our findings further narrowed down the adipogenic effect of Ad-36 to the function and activity of an intact E4 orf-1, which likely includes its PDZ-domain binding region. PDZ domains are found in over 400 human proteins. 28 As scaffolding proteins, PDZ domains mediate differentiation-inductive cocktail. The process of differentiation induced by adding 1-methyl-3-isobutylxanthanine, MDI to growth-arrested 3T1-L1 cells, concurrently activates cell cycle progression and upregulates cAMP and PI3K pathways leading to differentiation. cAMP signaling pathway includes activation of PKA, followed by activation of CREBP, which ultimately induces C/EBP-b expression 35, 36 and is critical for activation of PPARg and other downstream proadipogenic genes required for lipid accumulation. In the presence of MDI, Ad-36 enhances lipid accumulation in 3T3-L1 cells. 17 This study showed that even in the absence of MDI, Ad-36 and its E4 orf-1 gene mimicked MDI-induced modulation of adipogenic pathways leading ultimately to proliferation, differentiation and lipid accumulation in 3T3-L1 and hASC. The time course of cell number or lipid accumulation showed continued increase in the Ad-36 or Ad-36 E4 orf-1 groups. The controls remained almost at baseline levels during the time course, which should be expected due to a lack of adipogenic inducers in these groups. Considering the proliferative effect of Ad-36, the cellular lipid accumulation was normalized to cell number. Lipogenic effect of Ad-36 was significant even after normalization to cell number. This shows that Ad-36 increases both, cell number and lipid accumulation, in adipocyte progenitors. Although only a subset of cells is likely to be infected with Ad-36, collectively, the cells showed significantly greater adipogenesis compared to the mock-infected group. At this time, contribution of the subset of cells that are actually infected with Ad-36 to adipogenic response of the entire Ad-36 group of cells is unknown. Increased proliferation, differentiation and activation of PI3K in adipocytes results in greater insulin sensitivity. 8, 37 Therefore, the ability of Ad-36 to induce adipogenesis may be important for influencing insulin sensitivity. Indeed, Ad-36 infection of rats increased by several fold adipose tissue expression of many adipogenic genes including PPARg and C/EBP-b, reduced fasting insulin levels to 54% and significantly improved the HOMA index. 15 Moreover, Ad-36 infection of primary adipocytes increases glucose uptake. 32 It appears that Ad-36 E4 orf-1 protein or its cellular targets modulate adipogenesis as well as insulin sensitivity, which needs further investigation. Considering the activation of cAMP and PI3K pathways and the downstream adipogenic cascade by Ad-36 E4 orf-1, its cellular target appears to be upstream of these cell-signaling events in the adipogenic program.
Both an excess (obesity) and a paucity (lipodystrophy) of adipose tissue have been linked to insulin resistance. Pharmaceutical efforts have exploited the manipulation of adipogenesis to improve the metabolic profiles in these patients. For instance, adipogenesis induced by TZDs is considered to lower circulating free fatty acids levels, ultimately contributing to improved insulin sensitivity in type 2 diabetes 8, 9 even the in presence of obesity. 38, 39 On the other hand, insulin resistance of lipodystrophy [40] [41] [42] has been unsuccessfully treated with TZD. 43 The identification of Ad-36 E4 orf-1 as an adipogenic regulator suggests that it will provide a future target for therapeutic intervention.
In conclusion, we provide the mechanistic evidence of proadipogenic modulation of cellular processes in both rodent and human preadipocytes by a single viral gene, E4 orf-1.
